P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA

Detalles Bibliográficos
Autores principales: Hillengass, J., Cohen, A. D., Delforge, M., Einsele, H., Goldschmidt, H., Weisel, K., Raab, M.-S., Scheid, C., Schecter, J. M., De Braganca, K. C., Varsos, H., Yeh, T.-M., Mistry, P., Roccia, T., Corsale, C., Akram, M., Pacaud, L., Nesheiwat, T., Agha, M., Cohen, Y. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430739/
http://dx.doi.org/10.1097/01.HS9.0000846704.03590.a5
_version_ 1784779859009994752
author Hillengass, J.
Cohen, A. D.
Delforge, M.
Einsele, H.
Goldschmidt, H.
Weisel, K.
Raab, M.-S.
Scheid, C.
Schecter, J. M.
De Braganca, K. C.
Varsos, H.
Yeh, T.-M.
Mistry, P.
Roccia, T.
Corsale, C.
Akram, M.
Pacaud, L.
Nesheiwat, T.
Agha, M.
Cohen, Y. C.
author_facet Hillengass, J.
Cohen, A. D.
Delforge, M.
Einsele, H.
Goldschmidt, H.
Weisel, K.
Raab, M.-S.
Scheid, C.
Schecter, J. M.
De Braganca, K. C.
Varsos, H.
Yeh, T.-M.
Mistry, P.
Roccia, T.
Corsale, C.
Akram, M.
Pacaud, L.
Nesheiwat, T.
Agha, M.
Cohen, Y. C.
author_sort Hillengass, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9430739
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94307392022-08-31 P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA Hillengass, J. Cohen, A. D. Delforge, M. Einsele, H. Goldschmidt, H. Weisel, K. Raab, M.-S. Scheid, C. Schecter, J. M. De Braganca, K. C. Varsos, H. Yeh, T.-M. Mistry, P. Roccia, T. Corsale, C. Akram, M. Pacaud, L. Nesheiwat, T. Agha, M. Cohen, Y. C. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430739/ http://dx.doi.org/10.1097/01.HS9.0000846704.03590.a5 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hillengass, J.
Cohen, A. D.
Delforge, M.
Einsele, H.
Goldschmidt, H.
Weisel, K.
Raab, M.-S.
Scheid, C.
Schecter, J. M.
De Braganca, K. C.
Varsos, H.
Yeh, T.-M.
Mistry, P.
Roccia, T.
Corsale, C.
Akram, M.
Pacaud, L.
Nesheiwat, T.
Agha, M.
Cohen, Y. C.
P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title_full P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title_fullStr P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title_full_unstemmed P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title_short P959: CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA
title_sort p959: ciltacabtagene autoleucel in lenalidomide-refractory patients with progressive multiple myeloma after 1-3 prior lines of therapy: cartitude-2 biological correlative analyses and updated clinical data
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430739/
http://dx.doi.org/10.1097/01.HS9.0000846704.03590.a5
work_keys_str_mv AT hillengassj p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT cohenad p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT delforgem p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT einseleh p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT goldschmidth p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT weiselk p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT raabms p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT scheidc p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT schecterjm p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT debragancakc p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT varsosh p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT yehtm p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT mistryp p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT rocciat p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT corsalec p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT akramm p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT pacaudl p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT nesheiwatt p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT agham p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata
AT cohenyc p959ciltacabtageneautoleucelinlenalidomiderefractorypatientswithprogressivemultiplemyelomaafter13priorlinesoftherapycartitude2biologicalcorrelativeanalysesandupdatedclinicaldata

Ejemplares similares